Atai Therapeutics, Inc.
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06693609
- Locations
- π¬π§
MAC Clinical Research - South Staffordshire, Bridgetown, Cannock, Staffordshire, United Kingdom
π¬π§MAC Clinical Research - Greater Manchester, Manchester, Greater Manchester, United Kingdom
π¬π§MAC Clinical Research - Lancashire, Blackpool, Lancashire, United Kingdom
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Conditions
- Treatment Resistant Depression
- Interventions
- Drug: VLS-01-BU Placebo
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-10-02
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 142
- Registration Number
- NCT06524830
- Locations
- πΊπΈ
Noble Clinical Research, Tucson, Arizona, United States
πΊπΈPillar Clinical Research, LLC, Little Rock, Arkansas, United States
πΊπΈPreferred Research Partners, Inc., Little Rock, Arkansas, United States
A Study of Oral Ibogaine in Opioid Withdrawal
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- atai Therapeutics, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT05029401
- Locations
- π¬π§
MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, Manchester, Greater Mancherster, United Kingdom
π¬π§Hammersmith Medicines Research (HMR) Limited, London, United Kingdom